13 th AnnUAL MEETing | Washington, DC USA May 19-22, 2010 77Exhibitor DescriptionsAldevron3233 15 th Street, SouthFargo, ND 58104Telephone: (701) 297-9256Fax: (701) 280-1642E-mail: miller@aldevron.comWebsite: www.aldevron.comBooth Number: 506Aldevron is a leading contract manufacturing organization specializing in plasmidDNA, protein, antibody, DNA vaccine screening and genetic immunization(GIA) services. We manufacture biologics for research, clinical, and diagnosticapplications including ready-to-use AAV helper, cytokine, and reporter plasmids.Aldevron’s capacity and throughput capabilities support any project in bacterial,insect, and mammalian cell systems. By combining innovative technologies withbest-in-class project management, our team ensures that we consistently exceedyour expectations.<strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Gene</strong> & <strong>Cell</strong> <strong>Therapy</strong>555 East Wells StreetSuite 1100Milwaukee, WI 53202Telephone: (414) 278-1341Fax: (414) 276-3349E-mail: info@asgct.orgWebsite: www.asgct.orgBooth Number: 609 & 611Stop by the ASGCT membership booth to pick-up your Abstracts-on-Disc and theEducation Session CD. Find out where the 2011 Annual Meeting will be heldand other <strong>Society</strong> information.Biologics Consulting Group, Inc.1317 King StreetAlexandria, VA 22314Telephone: (703) 739-5695Fax: (703) 548-7457E-mail: mhawkins@bcg-usa.comWebsite: www.bcg-usa.comBooth Number: 401Biologics Consulting Group, Inc., is an international firm providing regulatoryand product development advice on the development and commercialization <strong>of</strong>biologicals, drugs, devices, diagnostics, and combination products. Since 1993,we have helped hundreds <strong>of</strong> products reach the marketplace. Our consultantscome from the executive/senior tiers <strong>of</strong> FDA and industry.BioSpherix, Ltd.19 Demott St.Lacona, NY 13083Telephone: (315) 387-3414Fax: (315) 387-3415E-mail: kmurray@biospherix.comWebsite: www.biospherix.comBooth Number: 210Closed-incubation-system for clinical cell cultures. Multiple, independent, highperformance, O2/CO2 incubators open into aseptic isolation modules with identicalcontrolled atmospheres for uninterrupted conditions during cell handling. Can bea cGMP compliant mini-facility, <strong>of</strong>fering cell and gene therapists an economical andpractical alternative to expensive brick-and-mortar walk-in clean rooms.Caliper Life Sciences68 Elm StreetHopkinton, MA 01748Telephone: (508) 435-9500Fax: (508) 435-3439Website: www.caliperls.comBooth Number: 514Caliper Life Sciences is a leading supplier <strong>of</strong> tools and services for life scienceresearch including IVIS in vivo imaging systems. IVIS is the most publishedplatform for sensitive fluorescence and bioluminescence imaging in both 2D and3D providing the insight to view complex biological interactions such as geneexpression or stem cell engraftment in longitudinal studies <strong>of</strong> whole animals.Center for <strong>Cell</strong>ular and Molecular Therapeutics at theChildren’s Hospital <strong>of</strong> PhiladelphiaRoom 5000Colket Translational Research Building3501 Civic Center Blvd.Philadelphia, PA 19104Telephone: (267) 426-5256Fax: (215) 590-3660E-mail: sunj@email.chop.eduBooth Number: 313
78<strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Gene</strong> & <strong>Cell</strong> <strong>Therapy</strong>Exhibitor DescriptionsData Unlimited International, Inc.15881-B Crabbs Branch WayRockville, MD 20855Telephone: (240) 631-7933Fax: (240) 631-7937E-mail: contact@duii.comWebsite: www.duii.comBooth Number: 211Starfruit Technologies® is s<strong>of</strong>tware/database/computer/barcode for DNAdiagnostic, genome/cancer research, immunogenetic labs – enables sample,patient, biorepository, billing databases; mutation, variant, disease, genotypedatabases, SNP databank; instrument interface, barcode, electronic signature,QA/QC; worksheet, workflow, inventory, protocol, image; epidemiologicalfrequency, trend, geographical distribution, disease/disorder susceptibility,reporting; comply with 21CFR11, CAP, CLIA, HIPPA, PHI.Elsevier - Academic Press15807 Quince Orchard RoadN. Potomac, MD 20878Telephone: (240) 477-8564Fax: (240) 477-8571E-mail: b.karafin@elsevier.comBooth Number: 406As the world’s leading publisher <strong>of</strong> science and health information, Elsevierserves more than 30 million scientists, students, and health and informationpr<strong>of</strong>essionals worldwide. Visit Elsevier for the latest clinical trial resources, suchas: Clinical and Translational Science: Principles <strong>of</strong> Human Research by DavidRobertson and Gordon H. Williams.Exemplar <strong>Gene</strong>tics958 N. MainSioux Center, IA 51250Telephone: (712) 722-2767Fax: (712) 722-2126E-mail: troy.arends@exemplargenetics.comWebsite: www.exemplargenetics.comBooth Number: 408Exemplar <strong>Gene</strong>tics is enabling discovery through the creation <strong>of</strong> large animalmodels <strong>of</strong> human disease. Through proprietary techniques and licensedprocesses, we have been successful in creating the only commercially availablelarge animal model that replicates human disease. These techniques can beutilized to create models <strong>of</strong> interest in any field.Institutional Biosafety Committee Services (IBC Services)2103 Harrison Av NWPMB 2436Olympia, WA 98502-2607Telephone: (360) 252-2850Fax: (360) 252-2820E-mail: ibcs@wirb.comWebsite: www.ibcservicepoint.comBooth Number: 505IBC Services establishes and provides administrative support for local IBCsreviewing gene transfer clinical trials and related rDNA research. We have servedmedical practices, hospitals and health systems, and VA and university settingsin 46 states and abroad. Broad experience from first-in-human and single-subjectprotocols to multicenter late-phase trials.Lovelace Respiratory Research Institute2425 Ridgecrest Dr. SEAlbuquerque, NM 87108Telephone: (505) 348-9457/9557Fax: (505) 348-4983E-mail: JBenson@LRRI.orgWebsite: www.lrri.orgBooth Number: 307The Lovelace Respiratory Research Institute is a private not-for-pr<strong>of</strong>it biomedicalresearch organization. Lovelace <strong>of</strong>fers animal models <strong>of</strong> disease, evaluation <strong>of</strong>efficacy <strong>of</strong> potential new therapeutics, and pre-clinical assessments includingevaluation <strong>of</strong> pharmacokinetics/biodistribution in large and small animalmodels. Studies are routinely performed under GLP guidelines.Mary Ann Liebert, Inc.140 Huguenot StreetNew Rochelle, NY 10801Telephone: (914) 740-2100Fax: (914) 740-2101E-mail: info@liebertpub.comWebsite: www.liebertpub.comBooth Number: 510Mary Ann Liebert, Inc., publishes authoritative peer-reviewed journals in newand promising areas <strong>of</strong> science and biomedical research including Human <strong>Gene</strong><strong>Therapy</strong>, (www.liebertpub.com/hum), named one <strong>of</strong> the 100 most influentialJournals in Biology & Medicine over the last 100 years! Visit us @ booth#510.EXHIBITOR PROSPECTUSfinal program
- Page 1 and 2:
FINAL PROGRAMAmerican Society of Ge
- Page 4:
13 th AnnUAL MEETing | Washington,
- Page 7 and 8:
6American Society of Gene & Cell Th
- Page 12 and 13:
13 th AnnUAL MEETing | Washington,
- Page 20 and 21:
13 th AnnUAL MEETing | Washington,
- Page 22 and 23:
13 th AnnUAL MEETing | Washington,
- Page 24 and 25:
13 th AnnUAL MEETing | Washington,
- Page 26 and 27:
13 th AnnUAL MEETing | Washington,
- Page 28 and 29: 13 th AnnUAL MEETing | Washington,
- Page 30 and 31: 13 th AnnUAL MEETing | Washington,
- Page 32 and 33: 13 th AnnUAL MEETing | Washington,
- Page 34 and 35: 13 th AnnUAL MEETing | Washington,
- Page 36 and 37: 13 th AnnUAL MEETing | Washington,
- Page 38 and 39: 13 th AnnUAL MEETing | Washington,
- Page 40 and 41: 13 th AnnUAL MEETing | Washington,
- Page 42 and 43: 13 th AnnUAL MEETing | Washington,
- Page 44 and 45: 13 th AnnUAL MEETing | Washington,
- Page 46 and 47: 13 th AnnUAL MEETing | Washington,
- Page 48 and 49: 13 th AnnUAL MEETing | Washington,
- Page 50 and 51: 13 th AnnUAL MEETing | Washington,
- Page 52 and 53: 13 th AnnUAL MEETing | Washington,
- Page 54 and 55: 13 th AnnUAL MEETing | Washington,
- Page 56 and 57: 13 th AnnUAL MEETing | Washington,
- Page 58 and 59: 13 th AnnUAL MEETing | Washington,
- Page 60 and 61: 13 th AnnUAL MEETing | Washington,
- Page 62 and 63: 13 th AnnUAL MEETing | Washington,
- Page 64 and 65: 13 th AnnUAL MEETing | Washington,
- Page 66 and 67: 13 th AnnUAL MEETing | Washington,
- Page 68 and 69: 13 th AnnUAL MEETing | Washington,
- Page 70 and 71: 13 th AnnUAL MEETing | Washington,
- Page 72 and 73: 13 th AnnUAL MEETing | Washington,
- Page 74 and 75: 13 th AnnUAL MEETing | Washington,
- Page 76 and 77: 13 th AnnUAL MEETing | Washington,
- Page 80 and 81: 13 th AnnUAL MEETing | Washington,
- Page 82 and 83: 13 th AnnUAL MEETing | Washington,
- Page 84 and 85: 13 th AnnUAL MEETing | Washington,
- Page 86 and 87: 13 th AnnUAL MEETing | Washington,
- Page 88 and 89: 13 th AnnUAL MEETing | Washington,
- Page 90 and 91: 13 th AnnUAL MEETing | Washington,
- Page 92 and 93: 13 th AnnUAL MEETing | Washington,
- Page 94 and 95: 13 th AnnUAL MEETing | Washington,
- Page 96 and 97: 13 th AnnUAL MEETing | Washington,
- Page 98 and 99: 13 th AnnUAL MEETing | Washington,
- Page 100 and 101: 13 th AnnUAL MEETing | Washington,
- Page 102 and 103: 13 th AnnUAL MEETing | Washington,
- Page 104 and 105: 13 th AnnUAL MEETing | Washington,
- Page 106 and 107: 13 th AnnUAL MEETing | Washington,
- Page 108 and 109: 13 th AnnUAL MEETing | Washington,
- Page 110 and 111: 13 th AnnUAL MEETing | Washington,
- Page 112 and 113: 13 th AnnUAL MEETing | Washington,
- Page 114 and 115: 13 th AnnUAL MEETing | Washington,
- Page 116 and 117: 13 th AnnUAL MEETing | Washington,
- Page 118 and 119: 13 th AnnUAL MEETing | Washington,
- Page 120 and 121: 13 th AnnUAL MEETing | Washington,
- Page 122 and 123: 13 th AnnUAL MEETing | Washington,
- Page 124 and 125: 13 th AnnUAL MEETing | Washington,
- Page 127 and 128: 126American Society of Gene & Cell
- Page 129 and 130:
128American Society of Gene & Cell
- Page 131 and 132:
130American Society of Gene & Cell
- Page 133 and 134:
132American Society of Gene & Cell
- Page 135 and 136:
134American Society of Gene & Cell
- Page 137 and 138:
136American Society of Gene & Cell
- Page 139 and 140:
138American Society of Gene & Cell
- Page 141 and 142:
140American Society of Gene & Cell
- Page 143 and 144:
142American Society of Gene & Cell
- Page 145 and 146:
144American Society of Gene & Cell
- Page 147 and 148:
146American Society of Gene & Cell
- Page 149 and 150:
148American Society of Gene & Cell
- Page 151 and 152:
150American Society of Gene & Cell
- Page 153 and 154:
152American Society of Gene & Cell
- Page 155 and 156:
154American Society of Gene & Cell
- Page 157 and 158:
156American Society of Gene & Cell
- Page 159 and 160:
158American Society of Gene & Cell
- Page 161 and 162:
160American Society of Gene & Cell
- Page 163 and 164:
162American Society of Gene & Cell
- Page 165 and 166:
164American Society of Gene & Cell
- Page 167 and 168:
166American Society of Gene & Cell
- Page 169 and 170:
168American Society of Gene & Cell
- Page 171 and 172:
170American Society of Gene & Cell
- Page 173 and 174:
172American Society of Gene & Cell
- Page 175 and 176:
174American Society of Gene & Cell
- Page 177 and 178:
176American Society of Gene & Cell
- Page 179 and 180:
178American Society of Gene & Cell
- Page 181 and 182:
180American Society of Gene & Cell
- Page 183 and 184:
182American Society of Gene & Cell
- Page 185 and 186:
184American Society of Gene & Cell
- Page 187 and 188:
186American Society of Gene & Cell
Change language